| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 73 |
| 1 | OMEPRAZOLE MAGNESIUM | 64 |
| 2 | DEXAMETHASONE | 63 |
| 3 | DEXAMETHASONE 1.5 MG | 63 |
| 4 | OMEPRAZOLE | 62 |
| 5 | ACETAMINOPHEN | 52 |
| 6 | OXALIPLATIN | 51 |
| 7 | METHOTREXATE SODIUM | 49 |
| 8 | ADALIMUMAB | 48 |
| 9 | PREDNISONE | 48 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZINC SULFATE HEPTAHYDRATE | 1 | 0.1429 |
| 1 | PHENTOLAMINE MESYLATE | 7 | 0.0432 |
| 2 | SENNA 8.6MG | 1 | 0.0185 |
| 3 | CARBON DIOXIDE | 2 | 0.0174 |
| 4 | SODIUM GLYCEROPHOSPHATE | 3 | 0.0082 |
| 5 | AURANOFIN | 1 | 0.0049 |
| 6 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 7 | SODIUM CARBONATE | 1 | 0.0043 |
| 8 | CAMPHOR, EUCALYPTUS OIL, MENTHOL | 1 | 0.0043 |
| 9 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE | 1 | 0.0042 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 183 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 118 |
| 2 | Proton Pump Inhibitor [EPC] | 95 |
| 3 | Platinum-based Drug [EPC] | 92 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 80 |
| 5 | Loop Diuretic [EPC] | 76 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 58 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 54 |
| 8 | Atypical Antipsychotic [EPC] | 46 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 45 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 1 | Vasopressin Receptor Agonist [EPC] | 1 | 0.0030 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 16 | 0.0027 |
| 3 | Vitamin D2 Analog [EPC] | 13 | 0.0018 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 15 | 0.0017 |
| 5 | Monobactam Antibacterial [EPC] | 4 | 0.0015 |
| 6 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 7 | Lipid Emulsion [EPC] | 3 | 0.0011 |
| 8 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 9 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |